Articles

Impact of a Breast Cancer Diagnosis on Finances and Marital Status in Young Women

Tamara Hamlish, Michelle L Foster, Sarah Strom, et al. BMC Womens Health. 2025 Feb 25;25(1):86

We conducted descriptive statistical analysis of survey data from 315 women diagnosed with breast cancer before age 45. We found significant changes following diagnosis in employment and insurance. Prior to diagnosis, 68.6% of respondents were employed full time, compared to 52.4% following diagnosis. Individuals ... Read More

13 May, 2026

Exploring the economic impact of breast cancers during the 18 months following diagnosis

Louisa Gordon, Paul Scuffham, Sandi Hayes, Beth Newman. Psychooncology. 2007 Dec;16(12):1130-9

The economic impact on individuals with breast cancer is not well understood. We sought to identify and describe the direct and indirect economic losses to breast cancer survivors in Australia. A longitudinal, population-based study of 287 women was used to explore economic outcomes (costs and lost income) for wome... Read More

13 May, 2026

The productivity burden of breast cancer in Australia

Melanie Lloyd, Divya Bassi, Ella Zomer, Zanfina Ademi. Cancer Epidemiol. 2025 Feb:94:102726

Breast cancer exerts a considerable burden on an individual's health but also impacts society more broadly through lost work productivity. This study aimed to measure the quality of life and productivity burden among Australian females of working age diagnosed with breast cancer in 2022. Over a ten-year period from... Read More

13 May, 2026

What affects the public healthcare costs of breast cancer in New Zealand?

Chunhuan Lao, Mohana Mondal, Marion Kuper-Hommel, et al. Asia Pac J Clin Oncol. 2023 Aug;19(4):482-492

This study aims to identify the factors that affect the public healthcare costs of stage I-III breast cancer and stage IV cancer in New Zealand. We identified 16,977 stage I-III and 1,093 stage IV breast cancer patients eligible for this study. The costs of stage I-III cancer in the second to fifth year post diagn... Read More

13 May, 2026

Global treatment costs of breast cancer by stage: A systematic review

Li Sun, Rosa Legood, Isabel Dos-Santos-Silva, et al. PLoS One. 2018 Nov 26;13(11):e0207993

This study aimed to conduct a systematic review to compare treatment costs of breast cancer by stage at diagnosis across countries at different levels of socio-economic development, and to identify key methodological differences in costing approaches. Twenty studies were included, 15 from high-income countries and... Read More

13 May, 2026

Results from a prospective longitudinal survey of employment and work outcomes in newly diagnosed cancer patients during and after curative-intent chemotherapy: A Wisconsin Oncology Network study

Amye J Tevaarwerk, Kris Kwekkeboom, Kevin A Buhr, et al. Cancer. 2021 Mar 1;127(5):801-808

Post cancer work limitations may affect a substantial proportion of patients and contribute to the "financial toxicity" of cancer treatment. The degree and nature of work limitations and employment outcomes are poorly understood for cancer patients, particularly in the immediate period of transition after active t... Read More

13 May, 2026

Breast cancer and long-term employment: A retrospective cohort study from Norway

Roy A Nielsen, Eliva Atieno Ambugo, Steffen Torp, et al. J Public Health Res. 2026 Jan 26;15(1):22799036251410249

Breast cancer and its treatment may contribute to an increased risk of unemployment, influenced by both disease-related factors and socioeconomic determinant. This retrospective study investigated long-term employment among breast cancer survivors (BCS) and assessed disease specific and socioeconomic factors assoc... Read More

13 May, 2026

Breast cancer-related mortality in Central and Eastern Europe: years of life lost and productivity costs

Goran Bencina, Nour Chami, Robert Hughes, et al. J Med Econ. 2023 Jan-Dec;26(1):254-261

Breast cancer (BC) poses a public health challenge as the most commonly diagnosed cancer among women globally. While BC mortality has declined across Europe in the past three decades, an opposite trend has been reported in some transitional European countries. The human capital approach (HCA) was used to estimate ... Read More

13 May, 2026

The productivity cost of mortality due to lung cancer, breast cancer and melanoma in Europe across 2010, 2015 and 2019

Agnes Brandtmüller, Anne Meiwald, Edward Oliver, et al. J Cancer Policy. 2024 Dec:42:100499

Cancer caused an estimated 2.2 million deaths across Europe in 2020. This analysis estimated the cost of lost productivity due to premature deaths associated with lung, breast and melanoma cancer and investigated the temporal trends across European regions across 2010, 2015 and 2019. The number of cancer deaths re... Read More

13 May, 2026

Medications to reduce breast cancer risk: a network meta-analysis of randomized controlled trials

Ghazaleh Pourali, Minglu Liu, Supriya S Sherpa, et al. Breast Cancer Res. 2025 Jul 1;27(1):118

Given the rising incidence of breast cancer, especially in premenopausal women, there is an urgent need to identify additional risk-reducing medications to accelerate prevention, as only a few are currently approved. Out of 8,598 studies screened, 43 RCTs (n = 337,240 women) met inclusion criteria. Six medications... Read More

13 May, 2026